Clinical Trial Update: 68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC) [Phase 2]

View source ↗

Summary

This clinical trial update concerns a Phase 2 study evaluating 68Ga-PSMA-11 PET-directed radioligand therapy in metastatic hepatocellular carcinoma. The trial s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• 68Ga-PSMA-11 (Gallium-68 labeled PSMA-11 radiopharmaceutical)

Snippet

Sponsor: Melissa Lumish | Conditions: Liver Cancer, Hepatocellular Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING